From July 26, 2022 to September 30, 2022, the company has repurchased 6,559,178 shares, representing 1.67% for $557.73 million. With this, the company has completed the repurchase of 6,559,178 shares, representing 1.67% for $557.73 million under the buyback announced on July 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.4 USD | +1.41% | -3.04% | +2.64% |
04-30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
04-26 | Wall Street: the worst week of 2024 is followed by the best | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.64% | 49.95B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.57B | |
+6.58% | 43.84B | |
+4.91% | 41.71B | |
+21.98% | 31.59B | |
+14.45% | 25.3B | |
-5.81% | 23.94B | |
-4.35% | 23.83B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on July 28, 2022.